🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro pen vs compounded vial - pros and cons? — July 2024 Page 5

Mounjaro pen vs compounded vial - pros and cons? — July 2024

kate.chem Sat, Aug 16, 2025 at 2:23 PM 37 replies 1,520 viewsPage 5 of 8
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Aug 16, 2025 at 9:28 PM#21

Congrats kate.chem!! You should be so proud of yourself. 🎉

13 18Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 10 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Aug 16, 2025 at 9:45 PM#22

Reading this thread on Mounjaro pen vs hits close to home. Dad of 2 checking in — I started at 293 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 68 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Mounjaro pen vs — take the leap. It was the best health decision I have ever made. ❤️

18 3LeilaHI, marcus_mpls, DeniseRN_TPA and 15 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Aug 16, 2025 at 10:02 PM#23

As a healthcare provider, I want to add some clinical context to this discussion on Mounjaro pen vs compounded vial - pros.

Building on what amy_econ_NJ said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Aug 17, 2025 at 12:02 AM
19 5mike.trainer_LA, sarah_nash92, FitDadDave and 16 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Aug 16, 2025 at 10:19 PM#24

Dr.EndoIndy — wow. This community is amazing.

26 6WendyG_ATL, SaraMom3, Dr.MetabolicMD and 23 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Aug 16, 2025 at 10:36 PM#25

Adding my data to this Mounjaro pen vs discussion:

MetricBaselineMonth 5Month 8
Weight246 lbs221 lbs221 lbs
A1C7.0%6.0%5.4%
hsCRP5.04.01.2

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

40 17Dr.DermMIA, fiona_VT, denise_HTX and 37 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register